# OnCo record paper-defibrotide-2005-01-blood-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-defibrotide-2005-01-blood-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-defibrotide-2005-01-blood-2016" ;
  schema:name "Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure"@en ;
  schema:description "The primary report of Study 2005-01: 38 percent of transplant patients with severe veno-occlusive disease and organ failure were alive at day 100 on defibrotide, against 25 percent of carefully matched historical controls."@en ;
  schema:url <https://onco.cc/key-papers/paper-defibrotide-2005-01-blood-2016/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1182/blood-2015-10-676924>, <https://pubmed.ncbi.nlm.nih.gov/26825712/>, <https://clinicaltrials.gov/study/NCT00358501> ;
  schema:sameAs <https://doi.org/10.1182/blood-2015-10-676924> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Richardson PG, Riches ML, Kernan NA, et al." ;
  onco:drugs <https://onco.cc/drugs/defibrotide/> ;
  onco:companies <https://onco.cc/companies/jazz/> ;
  onco:terms <https://onco.cc/terms/allogeneic-transplant/> ;
  onco:trials <https://onco.cc/trials/study-2005-01/> ;
  onco:people <https://onco.cc/people/paul-richardson/> ;
  onco:journals <https://onco.cc/journals/blood/> .